CorMedix Inc.
CRMD
$5.88
-$0.22-3.61%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 191.26% | 71.50% | -25.53% | -36.90% | -79.73% |
Total Depreciation and Amortization | 614.97% | 334.83% | 341.95% | 28.99% | -16.89% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 9.34% | 21.98% | 19.23% | 10.27% | 38.22% |
Change in Net Operating Assets | -851.82% | -156,506.41% | -179.44% | -155.47% | 143.19% |
Cash from Operations | 47.75% | -56.94% | -63.78% | -66.54% | -74.59% |
Capital Expenditure | 96.65% | 3.92% | -443.75% | -314.19% | -129.74% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -132.93% | 1,198.01% | 364.92% | 161.38% | 604.26% |
Cash from Investing | -150.89% | 1,177.08% | 362.75% | 160.90% | 31,563.16% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 2,324.18% | -67.19% | -78.44% | -- | -92.26% |
Repurchase of Common Stock | -- | -- | 29.69% | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 2,312.83% | -67.19% | -80.25% | -101.35% | -92.26% |
Foreign Exchange rate Adjustments | -150.00% | 119.05% | -150.00% | -134.78% | -84.81% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 155.44% | -79.93% | -19.74% | 52.66% | -10,055.09% |